$MRAI

Marpai, Inc.

Marpai provides third-party administration, pharmacy benefit management and value-oriented health plan services to self-insured employers in the U.S., primarily small and medium-sized companies and local government entities. It administers employee health benefit plans for clients, whose employees and family members are members of those plans. Marpai provides provider network access, member support, claims validation and payment, care management, and stop-loss insurance sourcing. It also offers actuarial and bill review services. Marpai earns revenue from health plan administration, in-house ancillary services and third-party vendor services. Its ancillary offerings include Clinical Care Management, Repricing Insights, Marpai PACCS and MarpaiRx, a national pharmacy benefit management program. Third-party services include network access fees and cost-containment services. The myMarpai app gives members access to benefits, costs, deductibles and telehealth. Marpai is headquartered in Tampa, Florida.

0
3
0

No SEC Form 4 filings for $MRAI in the last 30 days.

See all $MRAI insider activity →
Low

Marpai, Inc. (MRAI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 13, 2026, Robert Pons notified the Board of Directors (the “Board”) of Marpai, Inc. (the “Company”) of his dec

Marpai (MRAI) Q3 Revenue Rose 9.6% to $4.4M

Marpai (MRAI) reported Q3 2026 revenue of $4.4M, up 9.6% YoY. Operating loss narrowed to $2.5M, and net loss improved to $3.3M. The company cited customer growth and cost reductions as positive trends.

AI handles every call from healthcare providers to Marpai; 70% need no human help.

Marpai, Inc. (OTCQX: MRAI) reports that its AI agents, developed by Opyn, handle 100% of inbound provider calls, resolving 70% without human help. This has reduced provider call center costs by 40%. The AI integrates with existing systems, offering 24/7 support and detailed reporting. Marpai's deployment demonstrates the potential for AI to manage high-volume inquiries, allowing human staff to focus on complex cases.

MRAI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 3 news stories mentioning MRAI (Marpai, Inc.). Coverage has been balanced: 0 bullish, 3 neutral, and 0 bearish.

Recent MRAI coverage spans corporate actions, insider activity and earnings.

What's driving MRAI

  • Board turnover may shift governance and oversight, but the filing provides no operational or financial guidance changes.

    SEC EDGAR 8-K · Nov 16, 2026

  • Marpai (MRAI) reported Q3 2026 revenue of $4.4M, up 9.6% YoY. Operating loss narrowed to $2.5M, and net loss improved to $3.3M. The company cited customer growth and cost reductions as positive trends.

    tradingview.com · Nov 12, 2026

  • Marpai, Inc. (OTCQX: MRAI) reports that its AI agents, developed by Opyn, handle 100% of inbound provider calls, resolving 70% without human help. This has reduced provider call center costs by 40%. The AI integrates with existing systems, offering 24/7 support and detailed reporting. Marpai's deployment demonstrates the potential for AI to manage high-volume inquiries, allowing human staff to focus on complex cases.

    stocktitan.net · Oct 29, 2026

  • Turnaround progress plus balance-sheet actions (debt extensions and new preferred financing) should support downside risk, but revenue contraction and low cash remain key overhangs.

    prnewswire.com · Aug 13, 2026

  • The filing signals a new equity financing (Series A Preferred) with defined minimum and maximum proceeds, which can dilute common holders and affect near-term capital structure expectations.

    SEC EDGAR 8-K · Jul 31, 2026

AlphAI scores every news story that mentions MRAI with an AI model for sentiment and relevance, and aggregates insider trades from Marpai, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $MRAI

Score
$MRAILowExec change· resigned

Marpai, Inc. (MRAI): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 13, 2026, Robert Pons notified the Board of Directors (the “Board”) of Marpai, Inc. (the “Company”) of his dec

AI handles every call from healthcare providers to Marpai; 70% need no human help.

Marpai, Inc. (OTCQX: MRAI) reports that its AI agents, developed by Opyn, handle 100% of inbound provider calls, resolving 70% without human help. This has reduced provider call center costs by 40%. The AI integrates with existing systems, offering 24/7 support and detailed reporting. Marpai's deployment demonstrates the potential for AI to manage high-volume inquiries, allowing human staff to focus on complex cases.

Marpai Reports Second Quarter 2026 Financial Results

Marpai, Inc. (OTCQX: MRAI) reported Q2 2026 results for the three and six months ended June 30, 2026. Revenue fell to $8.6 million for six months ended June 30, 2026 from $10.1 million a year earlier. The company cited faster cost reductions improving gross margin, and amended debt maturities to 2028 and 2029. After quarter-end, it raised $12.1 million via a private placement.

$MRAIMedOffering· $12M · closed

Marpai, Inc. (MRAI): Entry into a Material Definitive Agreement

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 Marpai Announces $12 Million Private Placement led by Mitchell Companies Tampa, Florida — July 29, 2026 — Marpai, Inc. (“Marpai” or the “Company”) (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (“TPA”), and Pharmacy Benefit Ma

$MRAIMedAI 8/10

Marpai Announces $12 Million Private Placement led by Mitchell Companies

Marpai, Inc. (OTCQX: MRAI) said it completed securities purchase agreements for a $12 million private placement of newly designated convertible preferred stock led by Mitchell Companies. The deal sold 12,100 shares at $1,000 each with a $1.00 initial conversion price. Preferred holders receive an 8% dividend in common shares and convert on a liquidity event or qualified public offering.

$MRAIMedDebt financing

Marpai, Inc. (MRAI): Entry into a Material Definitive Agreement

Marpai, Inc. (MRAI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. false 0001844392 0001844392 2026-07-16 2026-07-16 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Repor

Related tickers